Lyell Immunopharma, Inc. Common Stock (NASDAQ: LYEL) last traded at $15.53, up 1.17% on the session. The quote above updates while this page is open; the figures below are drawn from Lyell Immunopharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Lyell Immunopharma, Inc. Common Stock trades on NASDAQ under the ticker LYEL. Its market capitalisation is $380.56 million.
Valuation measures for Lyell Immunopharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $380.56M |
|---|---|
| Enterprise value | $384.92M |
| Price / sales | 14094.99 |
| Price / book | 1.63 |
| Beta | 1.71 |
Trailing-twelve-month figures tagged in Lyell Immunopharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $27.0K |
|---|---|
| Net income (TTM) | -$248.48M |
| EPS (TTM) | -$12.65 |
| Operating margin | -949981.48% |
| Return on equity | -106.27% |
| Cash | $72.98M |
Range and volume for LYEL over the past 52 weeks.
| 52-week high | $45.00 |
|---|---|
| 52-week low | $10.56 |
| Volume | 99.0K |
| Average volume | 188.4K |
| Previous close | $15.35 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.